Catheter Change To Liabilities from 2010 to 2024

VTAK Stock   0.35  0.02  5.41%   
Catheter Precision Change To Liabilities yearly trend continues to be quite stable with very little volatility. Change To Liabilities may rise above about 474.5 K this year. From the period between 2010 and 2024, Catheter Precision, Change To Liabilities regression line of its data series had sample variance of 980.8 B and sample variance of 980.8 B. View All Fundamentals
 
Change To Liabilities  
First Reported
2010-12-31
Previous Quarter
451.9 K
Current Value
474.5 K
Quarterly Volatility
990.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Catheter Precision financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catheter Precision's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 3.7 M or Total Revenue of 419.9 K, as well as many indicators such as Price To Sales Ratio of 47.72, Dividend Yield of 0.0 or PTB Ratio of 1.1. Catheter financial statements analysis is a perfect complement when working with Catheter Precision Valuation or Volatility modules.
  
Check out the analysis of Catheter Precision Correlation against competitors.
For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.

Latest Catheter Precision's Change To Liabilities Growth Pattern

Below is the plot of the Change To Liabilities of Catheter Precision over the last few years. It is Catheter Precision's Change To Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Catheter Precision's overall financial position and show how it may be relating to other accounts over time.
Change To Liabilities10 Years Trend
Slightly volatile
   Change To Liabilities   
       Timeline  

Catheter Change To Liabilities Regression Statistics

Arithmetic Mean(1,158,167)
Coefficient Of Variation(85.51)
Mean Deviation846,022
Median(1,735,000)
Standard Deviation990,331
Sample Variance980.8B
Range2.2M
R-Value0.77
Mean Square Error430.1B
R-Squared0.59
Significance0.0008
Slope170,502
Total Sum of Squares13.7T

Catheter Change To Liabilities History

2024474.5 K
2023451.9 K
2021393 K

About Catheter Precision Financial Statements

Catheter Precision investors utilize fundamental indicators, such as Change To Liabilities, to predict how Catheter Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Change To Liabilities451.9 K474.5 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Catheter Precision is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catheter Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catheter Precision Stock. Highlighted below are key reports to facilitate an investment decision about Catheter Precision Stock:
Check out the analysis of Catheter Precision Correlation against competitors.
For more information on how to buy Catheter Stock please use our How to buy in Catheter Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Catheter Precision. If investors know Catheter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Catheter Precision listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
30.61
Revenue Per Share
0.604
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.22)
Return On Equity
(0.50)
The market value of Catheter Precision is measured differently than its book value, which is the value of Catheter that is recorded on the company's balance sheet. Investors also form their own opinion of Catheter Precision's value that differs from its market value or its book value, called intrinsic value, which is Catheter Precision's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Catheter Precision's market value can be influenced by many factors that don't directly affect Catheter Precision's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Catheter Precision's value and its price as these two are different measures arrived at by different means. Investors typically determine if Catheter Precision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Catheter Precision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.